このアイテムのアクセス数: 80

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
mbio.03331-24.pdf4.43 MBAdobe PDF見る/開く
タイトル: Coatomer complex I is required for the transport of SARS-CoV-2 progeny virions from the endoplasmic reticulum-Golgi intermediate compartment
著者: Hirabayashi, Ai
Muramoto, Yukiko  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-8706-3113 (unconfirmed)
Takenaga, Toru
Tsunoda, Yugo
Wakazaki, Mayumi
Sato, Mayuko
Fujita-Fujiharu, Yoko
Nomura, Norimichi  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-6330-2239 (unconfirmed)
Yamauchi, Koji
Onishi, Chiho
Nakano, Masahiro
Toyooka, Kiminori
Noda, Takeshi
著者名の別形: 平林, 愛
村本, 裕紀子
武長, 徹
角田, 優伍
若崎, 眞由美
佐藤, 繭子
藤田, 陽子
野村, 紀通
山内, 康司
大西, 千帆
中野, 雅博
豊岡, 公徳
野田, 岳志
キーワード: SARS-CoV-2
COPI
vesicular transport
発行日: 8-Jan-2025
出版者: American Society for Microbiology
誌名: mBio
巻: 16
号: 1
論文番号: e03331-24
抄録: SARS-CoV-2 undergoes budding within the lumen of the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), and the progeny virions are delivered to the cell surface via vesicular transport. However, the molecular mechanisms remain poorly understood. Using three-dimensional electron microscopic analysis, such as array tomography and electron tomography, we found that virion-transporting vesicles possessed protein coats on their membrane and demonstrated that the protein coat was coatomer complex I (COPI). During the later stages of SARS-CoV-2 infection, we observed a notable alteration in the distribution of COPI and ERGIC throughout the cytoplasm, suggesting their potential involvement in virus replication. Depletion of COPB2, a key component of COPI, led to the confinement of SARS-CoV-2 progeny virions within the ERGIC at the perinuclear region. While the expression levels of viral proteins within cells were comparable, this depletion significantly reduced the efficiency of virion release, leading to the significant reduction of viral replication. Hence, our findings suggest COPI as a critical player in facilitating the transport of SARS-CoV-2 progeny virions from the ERGIC. Thus, COPI could be a promising target for the development of antivirals against SARS-CoV-2.
記述: 新型コロナウイルスの細胞内増殖機構を解明 --COVID-19の創薬開発に期待--. 京都大学プレスリリース. 2024-12-03.
著作権等: © 2024 Hirabayashi et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
URI: http://hdl.handle.net/2433/291104
DOI(出版社版): 10.1128/mbio.03331-24
PubMed ID: 39611845
関連リンク: https://www.kyoto-u.ac.jp/ja/research-news/2024-12-03-2
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons